Skip to main content

Table 3 Comorbidities in the COVID-19 case group

From: Association of socio-economic deprivation with COVID-19 incidence and fatality during the first wave of the pandemic in Italy: lessons learned from a local register-based study

Variable

N

%

χ2(p) applied to age groups

χ2(p) applied to SEHDI groups

Comorbidity

 No

716

67.9

p = 0.000*

p = 0.731

 Yes

338

32.1

Type of comorbidity

 Cancer

36

3.4

p = 0.000*

p = 0.333

 Diabetes

70

6.6

p = 0.000*

p = 0.377

 Cardiovascular diseases

219

20.8

p = 0.000*

p = 0.559

 HIV infection

8

0.8

p = 0.382

p = 0.331

 Chronic lung diseases

46

4.4

p = 0.002*

p = 0.316

 Kidney diseases

33

3.1

p = 0.000*

p = 0.588

Other metabolic diseases

14

1.3

p = 0.022*

p = 0.070

Obesity:

 BMI between 30 and 40 kg/m2

13

1.2

p = 0.810

p = 0.824

 BMI > 40 kg/m2

10

1.0

p = 0.309

p = 0.822

 Liver diseases

12

1.1

p = 0.000*

p = 0.237

 Neurological diseases

34

3.2

p = 0.000*

p = 0.133

 Other diseases

53

5.0

p = 0.001*

p = 0.830

  1. Foggia province, Apulia Region, Italy
  2. * = statistical significance at p < .05 level